Introduced
by
To repeal the absolute prohibition on product liability lawsuits against drug companies for drugs that have been approved by the U.S. Food And Drug Administration (as long as there was no fraud or bribery involved). Instead of an absolute prohibition, a person could sue, but there would be a rebuttable presumption that an FDA-approve drug is not defective or unreasonably dangerous.
Referred to the Committee on Oversight, Elections, and Ethics
Reported without amendment
With the recommendation that the bill be referred to the Committee on Tort Reform.
Referred to the Committee on Tort Reform
